A 3-(4-nitronaphthen-1-yl) amino-benzoate analog as a bifunctional AKR1C3 inhibitor and AR antagonist: Head to head comparison with other advanced AKR1C3 targeted therapeutics

Wangtrakuldee, P; Adeniji, AO; Zang, TZ; Duan, L; Khatri, B; Twenter, BM; Estrada, MA; Higgins, TF; Winkler, JD; Penning, TM

Penning, TM (reprint author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, 1315 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.; Penning, TM (reprint author), Univ Penn, Ctr Excellence Environm Toxicol, Perelman Sch Med, 1315

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019; 192 ():

Abstract

Drugs used for the treatment of castration resistant prostate cancer (CRPC) include Abiraterone acetate (Zytiga (R)) and Enzalutamide (XTANDI (R)). Ho......

Full Text Link